ArticleBMC cancer2021

Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis).

Masahiro Yokoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.